Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NAAA | Q02083 | 1/20 | 0.56 |
| ▸ | NPSR1 | Q6W5P4 | 2/20 | 0.49 |
| ▸ | RAD52 | P43351 | 1/20 | 0.49 |
| ▸ | FAAH | O00519 | 1/20 | 0.47 |
| ▸ | DGKA | P23743 | 1/20 | 0.47 |
| ▸ | HTR2C | P28335 | 1/20 | 0.46 |
| ▸ | MAPT | P10636 | 1/20 | 0.46 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.46 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.46 |
| ▸ | HCAR2 | Q8TDS4 | 1/20 | 0.45 |
| ▸ | EPHX1 | P07099 | 1/20 | 0.44 |
| ▸ | ACHE | P22303 | 5/20 | 0.43 |
| ▸ | TSHR | P16473 | 2/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4889296 | 0.94 | NAAA (0.50) | NAAANPSR1RAD52FAAHDGKA | |
| SCHEMBL19632976 | 0.92 | NAAA (0.49) | NAAANPSR1RAD52FAAHDGKA | |
| SCHEMBL19288051 | 0.92 | NAAA (0.49) | NAAANPSR1RAD52FAAHDGKA | |
| SCHEMBL27560470 | 0.86 | ATM (0.44) | NAAANPSR1RAD52FAAHDGKA | |
| SCHEMBL4886375 | 0.85 | NAAA (0.45) | NAAANPSR1RAD52FAAHDGKA | |
| SCHEMBL4886378 | 0.85 | NAAA (0.45) | NAAANPSR1RAD52FAAHDGKA | |
| SCHEMBL17891961 | 0.85 | NAAA (0.64) | NAAANPSR1RAD52FAAHDGKA | |
| SCHEMBL872735 | 0.85 | NAAA (0.64) | NAAANPSR1RAD52FAAHDGKA | |
| SCHEMBL3504225 | 0.85 | NAAA (0.64) | NAAANPSR1RAD52FAAHDGKA | |
| SCHEMBL17891959 | 0.85 | NAAA (0.64) | NAAANPSR1RAD52FAAHDGKA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20080311635-A1 | PROCESS FOR THE PREPARATION OF (S)(+)-3-(AMINOMETHYL)-5-METHYLHEXANOIC ACID | DIPHARMA FRANCIS S.R.L. (IT) | 2008-12-18 | — | — | US | disclosed |
| EP-1992609-A1 | A process for the preparation of a (S)(+)-3-(aminomethyl)-5-methylhexanoic acid | Dipharma Francis S.r.l. (IT) | 2008-11-19 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080311635-A1 | PROCESS FOR THE PREPARATION OF (S)(+)-3-(AMINOMETHYL)-5-METHYLHEXANOIC ACID | ADH5, ALDH7A1, ADH1C | NAAA 906/4885NPSR1 1570/4885RAD52 3676/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.